DSOLV+^TM Drug delivery platform

Why DSOLV+^TM?

• Enhanced Bioavailability:
  Vesicle formation at the site of administration improves transport across mucosal and epithelial barriers.

• High Encapsulation Efficiency:
  DSOLV+^TM enables efficient loading and retention of therapeutic agents, including structurally complex biologics.

• Rapid Vesicle Formation:
  Ultra-fast hydration and dissolution deliver immediate availability of both drug and vesicle-forming components.

• Versatile Across Modalities:
  Compatible with small molecules, peptides, proteins, nucleic acids, and emerging therapeutic classes.

How It Works?

DSOLV+^TM formulations contain optimized combinations of vesicle forming-agents. Upon exposure to physiological conditions the system self-assembles into vesicle or vesicle-like structures including:

• bilayer and unilayer vesicles

• small unilamellar and multilamellar vesicles

• micelles

• lipid nanoparticles (LNPs)

• solid lipid nanoparticles (SLNs)

• nanostructured lipid carriers (NLCs)

• cubosomes, hexosomes and other non-lamellar supramolecular assemblies

These structures encapsulate and protect the therapeutic agent while facilitating efficient transport.

Flexible Delivery Formats:

DSOLV+^TM supports a wide range of dosage forms:

• Oral thin films

• Buccal & sublingual films or powders

• Nasal powders & vesicle‑forming sprays

• Pulmonary dry powders & nebulized solutions

• Ocular drops, films, and semi‑solid formulations

• Injectables (SC, IV, long-acting injectables)

• Reconstitutable solids for vesicle-forming solutions

Applications:

• Small molecule therapeutics

• Peptide therapeutics

• Biologics and oligonucleotides

• Enzymes

• Vitamins and Bioactive compounds

• Dietary supplements

• Nutraceuticals and Cosmeceuticals

• Herbal extracts and Functional ingredients